NCT00268385 2026-03-19Vorinostat and Temozolomide in Treating Patients With Malignant GliomasNational Cancer Institute (NCI)Phase 1 Active not recruiting83 enrolled
NCT03426891 2025-10-06Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed GlioblastomaH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed21 enrolled 12 charts